Roche Holding (QX) Stock Price - RHHBY

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 34.17 ▲ 34.17 (0.00%)
Company Name Stock Ticker Symbol Market Type
Roche Holding (QX) RHHBY Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.51 1.52% 34.17 34.22 34.00 34.07 33.66 16:49:34
Bid Price Ask Price Spread Spread % News
34.14 34.16 0.02 0.06% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,180 1,074,671 $ 34.1507 $ 36,700,741 1,189,944 28.74 - 35.90
Last Trade Time Type Quantity Stock Price Currency
16:37:08 formt 197 $ 34.17 USD

Roche Holding (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.47B 862.56M $ 10.45B - 2.82 862.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.98M $ - 0.00% - -

more financials information »

Roche Holding (QX) News

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RHHBY Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week34.9335.0433.1433.7157933k-0.76-2.18%
1 Month34.8235.933.1434.86511M-0.65-1.87%
3 Months32.735.931.80533.86171M1.474.50%
6 Months32.2435.931.80533.69931M1.935.99%
1 Year28.9135.928.7432.18681M5.2618.19%
3 Years32.0336.8225.2530.79851M2.146.68%
5 Years36.8238.540.00050732.12541M-2.65-7.20%

Roche Holding (QX) Description

Headquartered in Basel, Switzerland, Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. In 2017, the Roche Group employed about 94,000 people worldwide, invested 10.4 billion Swiss francs in R&D and posted sales of 53.3 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit
Your Recent History
Roche Hold..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190717 22:26:11